CERO THERAPEUTICS

cero-therapeutics-logo

CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.

#SimilarOrganizations #People #Financial #Website #More

CERO THERAPEUTICS

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2017-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.cero.bio

Total Employee:
1+

Status:
Active

Total Funding:
41.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Sitelinks Search Box Amazon Yoast WordPress SEO Plugin Google Maps


Similar Organizations

not_available_image

AffyXell Therapeutics

AffyXell Therapeutics develops novel mesenchymal stem cell therapies.

arkuda-therapeutics-logo

Arkuda Therapeutics

Arkuda Therapeutics is a pharmaceutical company.

atara-biotherapeutics-logo

Atara Biotherapeutics

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

avammune-therapeutics-logo

Avammune Therapeutics

Avammune Therapeutics is a drug discovery company.

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

central-european-research-centre-logo

Central European Research Centre

CERC is a Hungarian R&D company.

curamir-therapeutics-logo

Curamir Therapeutics

Curamir Therapeutics is a developer of miRNA-based cancer therapeutics.

excellthera-logo

ExCellThera

ExCellThera is an advanced clinical stage biotechnology company.

impact-therapeutics-logo

IMPACT Therapeutics

IMPACT Therapeutics is a China based Company.

imvaq-therapeutics-logo

IMVAQ Therapeutics

Imvaq Therapeutics is an innovative cancer immunotherapy company.

lacerta-therapeutics-logo

Lacerta Therapeutics

Lacerta Therapeutics is a clinical stage gene therapy company.

lunac-therapeutics-logo

Lunac Therapeutics

Lunac Therapeutics is a UK-based drug discovery company.

macomics-logo

Macomics

Macomics is an immuno-oncology company.

modulus-therapeutics-logo

Modulus Therapeutics

Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.

orthogon-therapeutics-logo

Orthogon Therapeutics

Orthogon Therapeutics is a drug development company.

profoundbio-logo

ProfoundBio

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

caraway-therapeutics-logo

Caraway Therapeutics

Rheostat Therapeutics is a bio therapeutics company.

stemson-therapeutics-logo

Stemson Therapeutics

Stemson Therapeutics is a pre-clinical stage cell therapy company.

werewolf-therapeutics-logo

Werewolf Therapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.

xios-therapeutics-logo

Xios Therapeutics

Xios Therapeutics is a biotechnology company .

Current Employees Featured

daniel-corey_image

Daniel Corey
Daniel Corey Founder and Chief Scientific Officer @ Cero Therapeutics
Founder and Chief Scientific Officer
2018-01-01

remus-vezan_image

Remus Vezan
Remus Vezan Chief Medical Officer @ Cero Therapeutics
Chief Medical Officer
2021-04-01

jordan-corey_image

Jordan Corey
Jordan Corey Chief Financial Officer @ Cero Therapeutics
Chief Financial Officer
2019-12-01

Founder


daniel-corey_image

Daniel Corey

Investors List

altitude-life-science-ventures_image

Altitude Life Science Ventures

Altitude Life Science Ventures investment in Series A - Cero Therapeutics

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series A - Cero Therapeutics

sequoia-capital-china_image

Sequoia Capital China

Sequoia Capital China investment in Series A - Cero Therapeutics

lyell-immunopharma_image

Lyell Immunopharma

Lyell Immunopharma investment in Series A - Cero Therapeutics

Official Site Inspections

http://www.cero.bio

  • Host name: 123.217.117.34.bc.googleusercontent.com
  • IP address: 34.117.217.123
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Cero Therapeutics"

Cero | Home

Tumor cell clearance reimagined. Our mission is to discover, translate, and deliver pioneering curative cell therapies that incorporate multiple forms of tumor clearance into single T cells.See details»

Cero Therapeutics - Crunchbase Company Profile

CERo Therapeutics, Inc. is a new cellular immunotherapy company. GlobeNewswire News Room โ€” CERo Therapeutics Holdings, Inc. Announces โ€ฆSee details»

CERo Therapeutics Holdings, Inc. (CERo Therapeutics Holdings, Inc ...

SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Cero Therapeutics Holdings, Inc., (NASDAQ:CERO) (โ€œCERoโ€) an innovative immunotherapy company seeking to โ€ฆSee details»

CERo Therapeutics Holdings, Inc. - Drug pipelines, Patents

Contact: Brian Atwood Chief Executive Officer [email protected] Investors: CORE IR [email protected]. Immunotherapy Cell Therapy AACR. ... The statistics for drugs in the โ€ฆSee details»

Home | CERO

The Coalition for the Ecological Recovery in Organics, or CERO, is a group of growers, independent companies, scientists, and environmental stewards who are focused on supporting the growing organic community in the U.S. and โ€ฆSee details»

CERo Therapeutics Holdings, Inc. (CERO) - Yahoo Finance Canada

See the company profile for CERo Therapeutics Holdings, Inc. (CERO) including business summary, industry/sector information, number of employees, business summary, corporate โ€ฆSee details»

Cero | Home

The CER platform. We are advancing a CER T-cell platform that potentially offers novel approaches for the treatment of both hematologic malignancies and solid tumors.See details»

Cero | Corporate Governance

Jan 25, 2024 Board Diversity Matrix as of January 25, 2024; Total Number of Directors: Gender Identity Female Male Non-binary Did not disclose gender; Directors: 2: 3: Demographic BackgroundSee details»

CERo Therapeutics, Inc. (CERo Therapeutics, Inc.) - ่ฏ็‰ฉ โ€ฆ

้กนไธŽ CERo Therapeutics, Inc. ็›ธๅ…ณ็š„ๆ–‡็Œฎ๏ผˆๅŒป่ฏ๏ผ‰ 2024-05-01 · Clinical cancer research : an official journal of the American Association for Cancer Research Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid โ€ฆSee details»

CERo Therapeutics - Work in biotech

CERo Therapeutics is developing cellular immunotherapies to create a new class of cancer therapeutics using recent insights from synthetic and T cell biology. Receptor mediated cell โ€ฆSee details»

CERo Therapeutics Holdings (CERO) Company Profile & Description

6 days ago CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its โ€ฆSee details»

CERo Therapeutics Holdings, Inc. Announces Progress in

Mar 6, 2025 CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to โ€ฆSee details»

Cero | Our Science

At CERo, we are integrating the most recent insights from synthetic and T cell biology to create a new generation of engineered T cells for treatment of cancer. Leveraging a natural immune โ€ฆSee details»

CERo Therapeutics Holdings, Inc. (CERO) - Yahoo Finance

Find the latest CERo Therapeutics Holdings, Inc. (CERO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... , Inc. Announces โ€ฆSee details»

CERO 3D Incubator and Bioreactor | Your Home for Cell Research

Suitable for a wide range of cell typesโ€”including stem cells, tumor cells, and even tissue biopsiesโ€”CERO 3D delivers high-quality 3D culture capabilities to labs of all sizes. With four โ€ฆSee details»

Meet 3D CERO Incubator and Bioreactor | Your Home for Cell โ€ฆ

The CERO 3D Incubator & Bioreactor is not just another tool in your lab; it's a game-changer for cell culture, setting new standards in precision, flexibility and scalability. This revolutionary โ€ฆSee details»

Cero | Investor Relations

The company has significant operating losses, with a net loss of $7.3 million for 2023, an accumulated deficit of $43.1 million, and $1.6 million in cash. CERo expects continued net โ€ฆSee details»

CERo Therapeutics Holdings, Inc. (CERO) Stock Price, News, Quote ...

Find the latest CERo Therapeutics Holdings, Inc. (CERO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... , Inc. Announces โ€ฆSee details»

New survey: U.S. biotechs warn tariffs could impede access to โ€ฆ

2 days ago WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the โ€ฆSee details»

Cero | CER Technology Platform

Therapeutic potential. CERo's platform provides a distinct approach to other immune-based therapies. The platform has the potential to recognize broad tumor types, and, by combining โ€ฆSee details»

linkstock.net © 2022. All rights reserved